| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
LGND
Ligand Pharma
|
Jul 13, 2026 | BUY |
Strong Buy
-22.3% avg upside
15 analysts
|
— | -3.4% |
|
CERT
Certara
|
Jul 08, 2026 | HOLD |
Buy
+94.0% avg upside
21 analysts
|
— | +3.8% |
|
SDGR
Schrodinger
|
Jul 08, 2026 | BUY |
Strong Buy
+74.5% avg upside
14 analysts
|
— | +0.0% |
|
SLP
Simulations Plus
|
Jul 08, 2026 | HOLD |
Buy
+108.0% avg upside
11 analysts
|
— | · |
|
DYAI
Dyadic International
|
Jul 07, 2026 | BUY |
Buy
3 analysts
|
— | · |
|
LFCR
Lifecore Biomedical
|
Jul 06, 2026 | BUY |
Strong Buy
+108.5% avg upside
9 analysts
|
— | -5.9% |
|
MXCT
MaxCyte
|
Jul 02, 2026 | BUY |
Strong Buy
+180.8% avg upside
5 analysts
|
— | +5.3% |
|
CDXS
Codexis
|
Jun 25, 2026 | BUY |
Strong Buy
+379.1% avg upside
13 analysts
|
— | +8.0% |
|
BLFS
BioLife Solutions
|
Jun 24, 2026 | BUY |
Strong Buy
+3.3% avg upside
17 analysts
|
— | -0.2% |
|
TKNO
Alpha Teknova
|
Jun 24, 2026 | BUY |
Strong Buy
+164.9% avg upside
7 analysts
|
— | · |
|
CYRX
CryoPort
|
Jun 24, 2026 | BUY |
Strong Buy
-9.8% avg upside
15 analysts
|
— | +4.2% |
|
RGEN
Repligen
|
Jun 24, 2026 | BUY |
Strong Buy
+17.1% avg upside
25 analysts
|
— | -0.7% |
|
OMCL
Omnicell
|
Jun 11, 2026 | BUY |
Strong Buy
+14.4% avg upside
12 analysts
|
— | +9.8% |
|
BHST
BioHarvest Sciences
|
Jun 08, 2026 | BUY |
Strong Buy
+335.7% avg upside
5 analysts
|
— | · |
|
RZLT
Rezolute
|
Jun 02, 2026 | HOLD |
Strong Buy
+120.2% avg upside
13 analysts
|
— | +18.8% |
|
PARK
Park Dental Partners, Inc.
|
Jun 02, 2026 | BUY |
Strong Buy
+7.4% avg upside
2 analysts
|
— | +5.4% |
|
INFU
InfuSystem Holdings
|
May 19, 2026 | BUY |
Strong Buy
+56.2% avg upside
7 analysts
|
— | +0.3% |
|
MRVI
Maravai Lifesciences Holdings
|
May 08, 2026 | BUY |
Strong Buy
+120.8% avg upside
17 analysts
|
$5.00
23.24% Downside
|
+25.6% |
|
OABI
OmniAb
|
May 08, 2026 | BUY |
Strong Buy
+265.1% avg upside
10 analysts
|
$7.00
227.16% Upside
|
+38.6% |
|
APYX
Apyx Medical
|
May 08, 2026 | BUY |
Strong Buy
+531.0% avg upside
11 analysts
|
$6.00
42.12% Upside
|
+16.1% |
|
HSTM
HealthStream
|
May 06, 2026 | BUY |
Buy
+5.6% avg upside
8 analysts
|
$40.00
40.83% Upside
|
+22.9% |
|
BZAI
Blaize Holdings
|
Mar 25, 2026 | BUY |
Strong Buy
+305.3% avg upside
6 analysts
|
— | +9.3% |
|
FLUT
Flutter Entertainment PLC
|
Feb 23, 2026 | BUY |
Strong Buy
+70.0% avg upside
39 analysts
|
— | -3.7% |
|
NOTVQ
Inotiv
|
Feb 06, 2026 | BUY |
Strong Buy
+201065.5% avg upside
6 analysts
|
— | · |
|
CSBR
Champions Oncology
|
Dec 16, 2025 | BUY |
Strong Buy
+49.4% avg upside
6 analysts
|
$12.00
112.02% Upside
|
-11.6% |
|
VUZI
Vuzix
|
Dec 09, 2025 | BUY |
Strong Buy
+195.0% avg upside
8 analysts
|
— | +2.3% |
|
CLOV
Clover Health Investments
|
Oct 10, 2025 | BUY |
Buy
-26.7% avg upside
9 analysts
|
— | +78.5% |
|
FSLY
Fastly
|
Jun 17, 2025 | HOLD |
Buy
+54.4% avg upside
25 analysts
|
— | +162.6% |
|
NEO
NeoGenomics
|
Apr 25, 2025 | BUY |
Strong Buy
+10.8% avg upside
17 analysts
|
— | -19.3% |
|
BWMN
Bowman Consulting Group
|
Mar 18, 2025 | BUY |
Strong Buy
+83.3% avg upside
11 analysts
|
— | +12.5% |
|
EHTH
Ehealth
|
Dec 18, 2024 | BUY |
Hold
+907.7% avg upside
19 analysts
|
— | -37.2% |
|
ISPC
iSpecimen
|
Aug 07, 2024 | BUY |
Strong Buy
+81.5% avg upside
3 analysts
|
— | -64.0% |
|
SRTS
Sensus Healthcare
|
Feb 09, 2024 | BUY |
Strong Buy
+119.2% avg upside
8 analysts
|
$6.00
94.90% Upside
|
+50.4% |
|
TSE:ELVA
Electrovaya
|
Sep 21, 2023 | BUY |
Strong Buy
+48.7% avg upside
11 analysts
|
— | · |
|
VIAOY
VIA optronics
|
Aug 30, 2023 | BUY |
Strong Buy
+5733.4% avg upside
3 analysts
|
— | -98.4% |
|
TDOC
Teladoc
|
Feb 23, 2023 | HOLD |
Buy
+218.6% avg upside
37 analysts
|
— | -47.1% |
|
ANGO
AngioDynamics
|
Oct 04, 2019 | HOLD |
Strong Buy
+31.8% avg upside
9 analysts
|
$17.00
30.67% Upside
|
-21.2% |
|
VIVE
Viveve Medical
|
Jan 18, 2019 | HOLD |
Buy
+79999900.0% avg upside
8 analysts
|
$100.00
49999899.99% Upside
|
-99.2% |
|
TECH
Bio-Techne
|
Oct 31, 2018 | HOLD |
Hold
+17.0% avg upside
21 analysts
|
$154.00
116.25% Upside
|
+25.0% |
|
MDXG
MiMedx Group
|
Feb 27, 2018 | BUY |
Strong Buy
+153.0% avg upside
17 analysts
|
$19.00
352.35% Upside
|
-59.4% |
|
HAE
Haemonetics
|
Nov 08, 2017 | HOLD |
Buy
-10.3% avg upside
17 analysts
|
$50.00
32.81% Downside
|
+112.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.